Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis

@article{Brunt2014TherapeuticSA,
  title={Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis},
  author={Tibor Markus Brunt and Marianne L.L. van Genugten and Kathrin H{\"o}ner-Snoeken and M. Van De Velde and Raymond J. M. Niesink},
  journal={Journal of Clinical Psychopharmacology},
  year={2014},
  volume={34},
  pages={344–349}
}
Abstract In The Netherlands, pharmaceutical-grade cultivated cannabis is distributed for medicinal purposes as commissioned by the Ministry of Health. Few studies have thus far described its therapeutic efficacy or subjective (adverse) effects in patients. The aims of this study are to assess the therapeutic satisfaction within a group of patients using prescribed pharmaceutical-grade cannabis and to compare the subjective effects among the available strains with special focus on their delta-9… 
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
TLDR
Oncologists should familiarize themselves with the available database to be able to better advise their patients on the potential uses of this complementary botanical therapy, and to evaluate whether the preclinical antitumor effects translate into benefit for cancer patients.
Medical Cannabis Use and Pain: An Experience Sampling Study
TLDR
The results imply that after long-term use, CP patients intend to use MC in response to pain experiences, yet they may not actually achieve the pain relief.
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
TLDR
The often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research, and the most commonly reported side effects were tiredness, diarrhea, and changes of appetite/weight.
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
TLDR
The often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research, and some important toxicological parameters are yet to be studied, for example, if CBD has an effect on hormones.
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
TLDR
A scoping literature review is conducted to describe the views and perceptions of adult patients who had consumed MC to relieve chronic CMP, finding that MC users suffering from CMP or other chronic non-cancer pain perceived more benefits than harms.
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes
  • A. Cortellini, G. Porzio, L. Verna
  • Medicine
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
  • 2019
TLDR
Most of Italian cancer patients know medical cannabis and a third of them have considered using cannabis to treat one (or more) of their own health problems, but they are poorly informed and do not tend to ask for information about medical cannabis to healthcare professionals.
Short- and Long-Term Effects of Cannabis on Headache and Migraine.
Should Oncologists Recommend Cannabis?
  • D. Abrams
  • Medicine, Biology
    Current Treatment Options in Oncology
  • 2019
TLDR
Oncologists and palliative care providers should recommend this botanical remedy to their patients to gain first-hand evidence of its therapeutic potential despite the paucity of results from randomized placebo-controlled clinical trials.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Systematic review and meta-analysis of cannabis treatment for chronic pain.
TLDR
Systematic review and meta-analysis of double-blind randomized controlled trials that compared any cannabis preparation to placebo among subjects with chronic pain suggests that cannabis treatment is moderately efficacious for treatment of chronic pain, but beneficial effects may be partially (or completely) offset by potentially serious harms.
Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
TLDR
The results support the idea that the psychoactive effects of marijuana in healthy volunteers are due primarily to THC.
Therapeutic aspects of cannabis and cannabinoids
  • P. Robson
  • Medicine
    British Journal of Psychiatry
  • 2001
TLDR
Cannabis and some cannabinoids are effective antiemetics and analgesics and reduce intraocular pressure and there is evidence of symptom relief and improved well-being in selected neurological conditions, AIDS and certain cancers.
Medical use of cannabis in the Netherlands
TLDR
Indications were neurologic disorders, pain, musculoskeletal disorders, and cancer anorexia/cachexia, and smoked cannabis was perceived as more effective than oral administration.
Cannabinoids in medicine: A review of their therapeutic potential.
TLDR
Cannabinoids present an interesting therapeutic potential as antiemetics, appetite stimulants in debilitating diseases, analgesics, and in the treatment of multiple sclerosis, spinal cord injuries, Tourette's syndrome, epilepsy and glaucoma.
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
TLDR
The increase in anxiety induced by the SPST on subjects with SAD was reduced with the use of CBD, resulting in a similar response as the HC, and no significant differences were observed between CBD and HC in SSPS-N scores or in the cognitive impairment, discomfort, and alert factors of VAMS.
Being stoned: a review of self-reported cannabis effects.
TLDR
Relaxation is the effect reported most commonly in naturalistic studies of cannabis users, irrespective of the method used, and there was considerable variation in the effects experienced.
Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.
TLDR
Data indicate that males and females access MC at approximately the same rate, with similar median authorization times, and major treatment access and delivery barriers remain.
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
TLDR
Repeated lower daily rimonabant doses (40 mg) attenuated the acute physiological effects of smoked cannabis to a similar degree as a single 90-mg dose; repeated 40-mg doses attenuated subjective effects after 8 but not 15 days.
...
1
2
3
4
5
...